Allergan layoffs, on the record
Every job cut, severance charge and restructuring Allergan reported in its annual reports, 2017 to 2019, quoted from the filings. Headcount went from approximately 17,800 to approximately 16,900.
Headcount, as reported
| Annual report | Employees | As of |
|---|---|---|
| 10-K for 2017 | approximately 17,800 | December 31, 2017 |
| 10-K for 2018 | approximately 16,900 | December 31, 2018 |
Job cuts, severance and restructuring
Our summaryCompany approved a new restructuring program to optimize operations and reduce costs and global headcount, intending to eliminate over 1,000 currently filled positions and eliminating about 400 open positions.
Word for word“In December 2017, the Company approved a new restructuring program intended to optimize and restructure its operations, while reducing costs and global headcount in anticipation of loss of exclusivity of several key revenue-generating products in 2018.” 10-K for 2017
Our summaryCommercial organization restructuring program eliminated filled and open positions, primarily affecting the General Medicine sales force.
Word for word“As a result of the commercial organization restructuring program, the Company recorded severance and other employee related charges of $16.9 million and eliminated approximately 200 filled positions and approximately 150 open positions.” 10-K for 2017
Our summaryResearch and development restructuring program to reduce costs by prioritizing the pipeline.
Word for word“As a result of the research and development restructuring program, the Company recorded severance and other employee related charges of $12.4 million and eliminated approximately 100 filled positions.” 10-K for 2017
Our summaryGlobal operations restructuring program to close a manufacturing facility in December 2018 and reduce headcount.
Word for word“As a result of the global operations restructuring program, the Company will close a manufacturing facility in December 2018 and reduce the Company's headcount by approximately 250 employees.” 10-K for 2017
Our summaryMid-year commercial initiative and December 2017 program reduced selling and marketing headcount, with further reductions planned across cost of sales, selling and marketing and general and administrative in 2018.
Word for word“As part of these initiatives, the Company has reduced its employee headcount within selling and marketing by approximately 350 as of December 31, 2017 and is reducing its employee headcount within cost of sales, selling and marketing and general and administrative by approximately 900 employees in the year ended December 31, 2018.” 10-K for 2017
Our summaryPlanned internal reduction of approximately 200 R&D employees and headcount reduction from integration of acquired businesses, with severance and restructuring costs.
Word for word“Acquisition, integration and restructuring charges in the year ended December 31, 2017 includes $37.1 million of severance and restructuring costs related to a planned internal reduction of approximately 200 R&D employees and reduction of headcount due to the integration of acquired businesses.” 10-K for 2017
Our summaryCompany announced a new restructuring program of its international commercial operations to eliminate selling and marketing positions.
Word for word“In the year ending December 31, 2018, the Company initiated a new restructuring program of its international commercial operations.” 10-K for 2018
Our summaryCompany expected a reduction of sales representatives internationally as part of 2018 restructuring programs.
Word for word“In the year ended December 31, 2018, the restructuring programs included charges associated with scaling our manufacturing plants and changes in the international commercial promotional focus in certain markets which include an anticipated reduction of approximately 200 sales representatives internationally.” 10-K for 2018
Our summaryCompany recorded severance and other employee related charges under restructuring programs in 2018.
Word for word“In the year ended December 31, 2018, the Company recorded severance and other employee related charges of $52.0 million, which includes $8.2 million of share-based compensation related to this program.” 10-K for 2018
Our summaryCompany recorded severance and other employee related charges related to the December 2017 restructuring program in 2018.
Word for word“In the year ending December 31, 2018, the Company incurred $14.1 million in severance and other employee related charges and $8.2 million of share-based compensation related to the restructuring program announced in December 2017.” 10-K for 2018
Our summaryCompany reduced selling and marketing headcount under restructuring initiatives in 2017.
Word for word“As part of these initiatives, the Company reduced its employee headcount within selling and marketing by approximately 350 as of December 31, 2017.” 10-K for 2018
Our summaryCompany recorded total restructuring charges related to continuing operations for 2018, 2017 and 2016.
Word for word“During the years ended December 31, 2018, 2017 and 2016, the Company recognized restructuring charges related to continuing operations of $52.0 million, $272.6 million and $106.1 million, respectively.” 10-K for 2018
| Fiscal year ended | Severance costs | Restructuring charges | Cash paid for restructuring |
|---|---|---|---|
| 2016-12-31 | — | $106.1 million | $115.2 million |
| 2017-12-31 | — | $272.6 million | $178 million |
| 2018-12-31 | $52 million | $52 million | $143.9 million |
| 2019-12-31 | — | $8.1 million | $68.3 million |
Allergan has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from Allergan’s annual reports (10-K for 2019, 10-K for 2018, 10-K for 2017) and the financial data it files with the SEC, as of 2020-02-18. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.